Literature DB >> 10633923

Detection of Onchocerca volvulus infection in Simulium ochraceum sensu lato: comparison of a PCR assay and fly dissection in a Mexican hypoendemic community.

M A Rodríguez-Pérez1, R Danis-Lozano, M H Rodríguez, T R Unnasch, J E Bradley.   

Abstract

Detection of Onchocerca volvulus larvae in vector populations is of prime importance in the assessment of the effectiveness of onchocerciasis control programmes. Traditionally, detection of larvae is attained by the dissection of flies, but this time-consuming method cannot easily discriminate between species of Onchocerca. The genome of all Onchocerca species has a unique 150 bp repeat, which can be amplified by PCR, and O. volvulus-specific DNA probes can detect these products by Southern blot (SB). This study optimizes a PCR/SB assay, and compares it with fly dissection to estimate the prevalence (p) and intensity of infection (m) in the local vector population of a Mexican community that has become hypoendemic as a result of 7 years of treatment with ivermectin and nodulectomy. The PCR detected 1 infected fly in a pool of 99 uninfected flies, but the optimal pool size was 50 flies. At the community level, 1 out of 10,550 flies was positive (p = 0.0095%, 95% confidence intervals CI = 0.00024-0.05280%; m = 0.00027 larvae/parous fly, CI = -0.00026-0.00081) by PCR, and 4 out of 10,772 flies (p = 0.0371%, CI = 0.01012-0.09505%; m = 0.00107 larvae/parous fly, 95% CI = 0.00002-0.00212) by dissection (observed m = 0.0005). Both methods produce statistically similar estimates of the prevalence and intensity, indicating that pool screening is a viable alternative for entomological surveillance in areas where the intensity of transmission is becoming extremely low as a result of control interventions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10633923     DOI: 10.1017/s0031182099005107

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  7 in total

1.  Transmission of Onchocerca volvulus continues in Nyagak-Bondo focus of northwestern Uganda after 18 years of a single dose of annual treatment with ivermectin.

Authors:  Moses N Katabarwa; Tom Lakwo; Peace Habomugisha; Stella Agunyo; Edson Byamukama; David Oguttu; Ephraim Tukesiga; Dickson Unoba; Patrick Dramuke; Ambrose Onapa; Edridah M Tukahebwa; Dennis Lwamafa; Frank Walsh; Thomas R Unnasch
Journal:  Am J Trop Med Hyg       Date:  2013-05-20       Impact factor: 2.345

2.  Biting behaviour of Simulium damnosum complex and Onchocerca volvulus infection along the Osun River, Southwest Nigeria.

Authors:  Monsuru A Adeleke; Chiedu F Mafiana; Sammy O Sam-Wobo; Ganiyu O Olatunde; Uwem F Ekpo; Olaoluwa P Akinwale; Laurent Toe
Journal:  Parasit Vectors       Date:  2010-10-07       Impact factor: 3.876

3.  Using molecular data for epidemiological inference: assessing the prevalence of Trypanosoma brucei rhodesiense in tsetse in Serengeti, Tanzania.

Authors:  Harriet K Auty; Kim Picozzi; Imna Malele; Steve J Torr; Sarah Cleaveland; Sue Welburn
Journal:  PLoS Negl Trop Dis       Date:  2012-01-31

4.  Evaluating the diagnostic test accuracy of molecular xenomonitoring methods for characterising the community burden of Onchocerciasis.

Authors:  Joseph Pryce; Thomas R Unnasch; Lisa J Reimer
Journal:  PLoS Negl Trop Dis       Date:  2021-10-12

5.  Contribution of migrant coffee labourers infected with Onchocerca volvulus to the maintenance of the microfilarial reservoir in an ivermectin-treated area of Mexico.

Authors:  Mario A Rodríguez-Pérez; Aldo Segura Cabrera; Cristian Lizarazo Ortega; María-Gloria Basáñez; John B Davies
Journal:  Filaria J       Date:  2007-12-18

Review 6.  Diagnostics for onchocerciasis in the era of elimination.

Authors:  Thomas R Unnasch; Allison Golden; Vitaliano Cama; Paul T Cantey
Journal:  Int Health       Date:  2018-03-01       Impact factor: 2.473

7.  Transitioning from river blindness control to elimination: steps toward stopping treatment.

Authors:  Paul T Cantey; Sharon L Roy; Daniel Boakye; Upendo Mwingira; Eric A Ottesen; Adrian D Hopkins; Yao K Sodahlon
Journal:  Int Health       Date:  2018-03-01       Impact factor: 3.131

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.